Product
Pegylated interferon-alfa-2a
1 clinical trial
1 indication
Indication
Hepatitis DClinical trial
An Open-label, Dose-ranging, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Lonafarnib With and Without Ritonavir Boosting in Patients Chronically Infected With Delta Hepatitis (HDV) (LOWR-1)Status: Completed, Estimated PCD: 2015-09-01